University of Iowa Holden Comprehensive Cancer Center
- Research works
- 100 ▲ 46% vs 2013–17
- Citations
- 3.8k 38.3 per fractional work
- Top-10% rate
- 21.4% record average 16.5%
- Open access
- 46% world 28%
Not ranked overall: University of Iowa Holden Comprehensive Cancer Center is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.7×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.7×
- Medicine 3.7×
- Immunology and Microbiology 2.8×
- Nursing 2.8×
- Dentistry 1.1×
- Economics, Econometrics and Finance 0.8×
- Decision Sciences 0.6×
- Mathematics 0.5×
- Health Professions 0.3×
- Environmental Science 0.1×
- Materials Science 0.1×
- Engineering 0.0×
- Psychology 0.0×
- Computer Science 0.0×
Which keywords describe research at University of Iowa Holden Comprehensive Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Neoadjuvant Therapy, Molecular Characterization, Tumor Microenvironment, Prognostic Factors, Guidelines and Bladder Cancer.
- Risk Factors
- Immune Checkpoint Blockade
- Cancer
- Genetic Mutations
- Bladder Cancer
- Guidelines
- Molecular Characterization
- Chemotherapy
- Immunotherapy
- Neoadjuvant Therapy
- Tumor Microenvironment
- Prognostic Factors
- Urothelial Carcinoma
- Targeted Therapy
- Clinical Trials
- PD-1 and PD-L1
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Immunotherapy4▲ 26×9 topics
- Chemotherapy4▲ 26×14 topics
- Neoadjuvant Therapy2▲ 47×5 topics
- Molecular Characterization2▲ 53×3 topics
- Tumor Microenvironment2▲ 20×5 topics
- Guidelines2▲ 17×3 topics
- Prognostic Factors2▲ 19×8 topics
- Bladder Cancer2▲ 198×1 topic
- Urothelial Carcinoma2▲ 171×1 topic
- Genetic Mutations1▲ 16×5 topics
- Targeted Therapy1▲ 27×4 topics
- Cancer1▲ 4.2×10 topics
- Clinical Trials1▲ 8.2×7 topics
- Immune Checkpoint Blockade1▲ 47×1 topic
- PD-1 and PD-L11▲ 47×1 topic
- Risk Factors1▲ 5.0×7 topics
Which research topics does University of Iowa Holden Comprehensive Cancer Center publish most on?
By volume in 2022–2025: Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments and Urinary and Genital Oncology Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Bladder and Urothelial Cancer Treatments Surgery 2 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 3 Cancer Research and Treatments Biotechnology 1 works
- 4 Urinary and Genital Oncology Studies Surgery 1 works
- 5 Neuroendocrine Tumor Research Advances Epidemiology 1 works
- 6 Global Cancer Incidence and Screening Oncology 0 works
- 7 Amino Acid Enzymes and Metabolism Biochemistry 0 works
- 8 Cancer Genomics and Diagnostics Cancer Research 0 works
- 9 Immunotherapy and Immune Responses Immunology 0 works
- 10 RNA modifications and cancer Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has University of Iowa Holden Comprehensive Cancer Center's research output changed?
Output in 2018–2022 was 46% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Iowa City
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.